$22.75
4.0821.85%
Last update: Nov 10, 9:18 AM
City Therapeutics Inc
CTYNASDAQ
The average analyst price target for City Therapeutics is $37.33, 64.1% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $32 to $46. The latest change came on Nov 10, 2026, when Jefferies initiated coverage of City Therapeutics with a Buy rating and a $32 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
